BioTime Inc said on Wednesday its Renevia system succeeded in meeting the main goal of a pivotal European trial for facial wasting associated with treatment for HIV, putting it on track to file for European approval this year.
Reuters Health Information
from # All Medicine by Alexandros G. Sfakianakis via ola Kala on Inoreader http://ift.tt/2rlGhgx
via IFTTT
Παρασκευή 16 Ιουνίου 2017
BioTime's Renevia Succeeds in Pivotal European Facial Wasting Trial
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Recent research suggests that exercise stereotypes may influence physical activity through ego depletion and internalization mechanisms. The...
-
Publication date: Available online 16 June 2017 Source: Radiotherapy and Oncology Author(s): Mary McLay, Adrienne Stedford, Emily Yurkow...
-
Volume 10, Issue 2-3 , June - October 2016, Page ebi-ebi . from Med TandfOnline via Αλέξανδρος Σφακιανάκης on Inoreader http://ift.tt/2e...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου